These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 10757837)

  • 1. Why do neuroprotective drugs work in animals but not humans?
    DeGraba TJ; Pettigrew LC
    Neurol Clin; 2000 May; 18(2):475-93. PubMed ID: 10757837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging neuroprotective drugs for the treatment of acute ischaemic stroke.
    Schmidt A; Minnerup J; Kleinschnitz C
    Expert Opin Emerg Drugs; 2013 Jun; 18(2):109-20. PubMed ID: 23600899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methodological quality of animal studies of neuroprotective agents currently in phase II/III acute ischemic stroke trials.
    Philip M; Benatar M; Fisher M; Savitz SI
    Stroke; 2009 Feb; 40(2):577-81. PubMed ID: 19074479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toward wisdom from failure: lessons from neuroprotective stroke trials and new therapeutic directions.
    Gladstone DJ; Black SE; Hakim AM;
    Stroke; 2002 Aug; 33(8):2123-36. PubMed ID: 12154275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Future of neuroprotection for acute stroke: in the aftermath of the SAINT trials.
    Savitz SI; Fisher M
    Ann Neurol; 2007 May; 61(5):396-402. PubMed ID: 17420989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fast neuroprotection (fast-NPRX) for acute ischemic stroke victims: the time for treatment is now.
    Lapchak PA
    Transl Stroke Res; 2013 Dec; 4(6):704-9. PubMed ID: 24323424
    [No Abstract]   [Full Text] [Related]  

  • 7. Incrementally applied multifaceted therapeutic bundles in neuroprotection clinical trials...time for change.
    Kofke WA
    Neurocrit Care; 2010 Jun; 12(3):438-44. PubMed ID: 20146027
    [No Abstract]   [Full Text] [Related]  

  • 8. Tirilazad mesylate in acute ischemic stroke: A systematic review. Tirilazad International Steering Committee.
    Stroke; 2000 Sep; 31(9):2257-65. PubMed ID: 10978061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current therapies in ischemic stroke. Part B. Future candidates in stroke therapy and experimental studies.
    Broussalis E; Trinka E; Killer M; Harrer A; McCoy M; Kraus J
    Drug Discov Today; 2012 Jul; 17(13-14):671-84. PubMed ID: 22405898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Translating promising preclinical neuroprotective therapies to human stroke trials.
    Cook DJ; Tymianski M
    Expert Rev Cardiovasc Ther; 2011 Apr; 9(4):433-49. PubMed ID: 21517728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Past, present and future of neuroprotection].
    Mracek J
    Cas Lek Cesk; 2010; 149(12):586-90. PubMed ID: 21387585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Animal models of stroke: do they have value for discovering neuroprotective agents?
    Richard Green A; Odergren T; Ashwood T
    Trends Pharmacol Sci; 2003 Aug; 24(8):402-8. PubMed ID: 12915049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1,026 experimental treatments in acute stroke.
    O'Collins VE; Macleod MR; Donnan GA; Horky LL; van der Worp BH; Howells DW
    Ann Neurol; 2006 Mar; 59(3):467-77. PubMed ID: 16453316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recommendations for standards regarding preclinical neuroprotective and restorative drug development.
    Stroke Therapy Academic Industry Roundtable (STAIR)
    Stroke; 1999 Dec; 30(12):2752-8. PubMed ID: 10583007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Development of new stroke therapies: outlook for neuroprotective drugs].
    Rogalewski A; Schäbitz WR
    Nervenarzt; 2008 Feb; 79(2):218-24. PubMed ID: 18214414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anesthetic neuroprotection: antecedents and an appraisal of preclinical and clinical data quality.
    Ishida K; Berger M; Nadler J; Warner DS
    Curr Pharm Des; 2014; 20(36):5751-65. PubMed ID: 24502575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical trials with neuroprotective drugs in acute ischaemic stroke: are we doing the right thing?
    De Keyser J; Sulter G; Luiten PG
    Trends Neurosci; 1999 Dec; 22(12):535-40. PubMed ID: 10542428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [In vivo exploration of cerebral ischemia: use of neuroprotective agents in animal studies].
    Lestage P; Lockhart B; Roger A
    Therapie; 2002; 57(6):554-63. PubMed ID: 12666263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotection for ischemic stroke: two decades of success and failure.
    Cheng YD; Al-Khoury L; Zivin JA
    NeuroRx; 2004 Jan; 1(1):36-45. PubMed ID: 15717006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotection for ischaemic stroke: translation from the bench to the bedside.
    Sutherland BA; Minnerup J; Balami JS; Arba F; Buchan AM; Kleinschnitz C
    Int J Stroke; 2012 Jul; 7(5):407-18. PubMed ID: 22394615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.